Discontinuation report XARELTO

Last updated on 2018-12-05 History
Report ID 68808
Drug Identification Number 02441535
Brand name XARELTO
Common or Proper name rivaroxaban
Company Name BAYER INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) RIVAROXABAN RIVAROXABAN
Strength(s) 15MG 20MG
Dosage form(s) TABLET KIT
Route of administration ORAL
Packaging size 49
ATC code B01AF
ATC description ANTITHROMBOTIC AGENTS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2018-12-01
Actual discontinuation date 2018-12-01
Remaining supply date 2018-12-01
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 2920 MATHESON BLVD EAST
MISSISSAUGA, ONTARIO
CANADA L4W 5R6
Company contact information 1-800-265-7382

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2018-12-05 French Compare
v2 2018-12-05 English Compare
v1 2018-12-05 English Compare